TCS 2210

CAS No. 1201916-31-5

TCS 2210( —— )

Catalog No. M27725 CAS No. 1201916-31-5

TCS 2210 is an inducer of neuronal differentiation in mesenchymal stem cells and increases the neuronal markers β-III tubulin expression and neuron-specific enolase expression.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 187 In Stock
2MG 119 In Stock
5MG 182 In Stock
10MG 274 In Stock
25MG 468 In Stock
50MG 630 In Stock
100MG 896 In Stock
200MG Get Quote In Stock
500MG 1795 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TCS 2210
  • Note
    Research use only, not for human use.
  • Brief Description
    TCS 2210 is an inducer of neuronal differentiation in mesenchymal stem cells and increases the neuronal markers β-III tubulin expression and neuron-specific enolase expression.
  • Description
    TCS 2210 is an inducer of neuronal differentiation in mesenchymal stem cells and increases the neuronal markers β-III tubulin expression and neuron-specific enolase expression.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1201916-31-5
  • Formula Weight
    323.35
  • Molecular Formula
    C18H17N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O\N=C(/O)c1ccc2[nH]c(=O)c(CCCc3ccccc3)nc2c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Dhull DK, et al. Neuroprotective effect of cyclooxygenase inhibitors in ICV-STZ induced sporadic Alzheimer's disease in rats. J Mol Neurosci. 2012 Jan;46(1):223-35.
molnova catalog
related products
  • Tisotumab

    Tisotumab (Anti-Human F3 Recombinant Antibody) is a human IgG1 monoclonal antibody targeting tissue factor (TF), utilized in antibody-conjugating drugs for cancer research.

  • IR820-PTX

    IR820-PTX is a nanoparticle composed of IR-820 and paclitaxel that is highly permeable and tumor-targeting.IR820-PTX can be used for near-infrared fluorescence imaging and tumor diagnostics.

  • Gypenoside LXXV

    Gypenoside LXXV, isolated from Gynostemma pentaphyllum, is one of the deglycosylated shapes of ginsenoside Rb1. Gypenoside LXXV significantly reduces cancer cell viability and displays an anti-cancer effect.